RJ Reynolds
Chapter 11: Passive Smoking and Heart Disease: Epidemiology, Physiology, and Biochemistry.
Fields
- Request
- Court
- Order
- 19960800
- Minnesota
- 4rfp9
- 1rfp93
- Mangini
- Referenced Document
- List of Footnotes. Northwick Park Heart Study. Framingham Study.
- Box
- Rjr2088
- Site
- Government Relations
- State Government Relations
- Murray Js
- Regional Dir
- Date Loaded
- 27 Feb 1998
- Type
- REPORT
- Author
- Smith, C.J.
- Named Person
- Glantz, S.A.
- Parmley, W.W.
- Aronow
- Natl Cholesterol Education Program
- Roberts, W.C.
- American Journal, O.F. Cardiology
- Rogers
- Fisher
- Turner
- Topping
- Raymond
- Hojnacki
- Epa
- Fda
- Naaqs
- Horvath, S.M.
- Institute, O.F. Environmental Stress
- Univ, O.F. Ca
- Gillis
- Lee
- Svendsen
- Helsing
- Hirayama
- Garland
- Humble
- Marti, N.
- He
- Hole
- Oliver, M.F.
- Sidney
- Myers
- UCSF Legacy ID
- gvj24d00
Document Images
CHAPTER 11: PASSIVE SMOKING AND HEART DISEASE:
EPIDEMIOLOGY, PHYSIOLOGY, AND BIOCHEMISTRY
CARR J. SMITH, PH.D.
SENIOR SCIENTIST

CARR JOSEPH SMITH
Birthdate: January 11, 1957 Married, 3 children
U.S. Citizen
Current January 1989 - Present
Position: Senior Scientist, R. J. Reynolds Tobacco Co.
December 1986 - January 1989;
R & D Scientist, R. J. Reynolds Tobacco Co.
September 1986 - Present
Adjunct .Instructor of Pathology,
University of South Alabama College of Medicine
Education: B.S. Biology, Minor in Chemistry. University
of South Alabama, 1978.
Ph.D. Molecular Biophysics. Florida State
University, 1984.
Teaching
Experience: Spring, 1985 and 1986. Course coordinator for
"Understanding Cancer", University of South Alabama
Department of Allied Health
Work September 1986 - November 1986: Staff Fellow, Food
Experience: and Drug Administration
September 1984 - August 1986: Instructor of
Pathology and Allied Health,
University of South Alabama College of Medicine
Publications:
1. Carr Smith, Harold E. Van Wart, and David E. Schwartz, A
Quantitative Assay for the Hydrolysis of Structurally Intact
Basement Membranes, Anal. Biochem., 139, p.448-458 (1984).
2. C. J. Smith, J. C. Smith, and M. C. Finn. Possible Role
of Mast Cells (Allergy) in the Production of Keloid and
Hypertrophic Scar, Journal of Burn Care and Rehabilitation,
Vol. 8, No. 2, p. 125-131 (1987). (Cited in Skin and
Allergy News, June 1987.)
r

3. C. J. Smith and W. A. Gardner. Inflammation-Pro-
liferation: Possible Relationships in the Prostate, Chapter
3, section 5, in Current Concepts in Prostate Cancer, ed. D.
S. Coffey, N. Bruchovsky, W. A. Gardner, M. I., Resni.ck, J.
P. Karr; Alan R. Liss, New Y-ork, 1987, p. 317-325.
4. C. J. Smith, A. M. Leggett, and J. J. Lefante. Allergic
Etiology of Benign Fibrocystic Changes of the Breast, Medical
Hypotheses, 24, p. 21-28 (1987).
5. Carr J. Smith. Effect of a Low-Fat Diet on Hormone Levels in
Women with Cystic Breast Disease, Letter to the editor in
JNCI, Vol. 79, No. 3, September 1987, p. 607.
6. Denys F. LeClerc, Carr J. Smith, and E. Clifford Toren,
Jr. Axial Dispersion in Coiled Tubular Reactors, Analytica
Chimica Acta, 194 (1987) P. 109-117.
7. E. C. Toren and C. J. Smi th. HPLC of Isoenzymes, book
chaptei acc:epted for pubiica tion in 'riPLi of PY'oteins and
Macromolecules, editor, Fre d Regnier. Mar cel Dekker, Inc.
8. B.S. Baliga, L.J. Sindel, C.J. Smith, L.D. Jenkins, A.
Bendich, and V.N. Mankad. Chemiluminescence Response of
Polymorphonuclear Leukocytes From Vitamin E Deficient Sickle
Cell Patients, Nutrition Reports International, Vol. 39, No.
4, 1989, P. 761-771.
Presentations (Last two years):
"The Possible Role of Mast Cells (Allergy) in the Production
of Keloid and Hypertrophic Scarring". Presented at Surgery
Grand Rounds, November 12, 1987, to the Department of Surgery,
University of North Carolina, Chapel Hill.
"Development of a Human Chromosome - Intact Hepatocyte Co-
Cultivation System for Assessment of Mutagenicity". Presented
at the RJR Nabisco Science Forum, November 16, 1988.
References:
William A. Gardner, M.D.
Chairman of Pathology
University of South Alabama
(205) 471-7790
E. Clifford Toren, Jr., Ph.D.
Professor of Pathology
University of South Alabama
(205) 471-7321

Surrendra B. Baliga, Ph.D.
Associate Professor of Pediatrics
University of South Alabama
(205) 471-7099

A REVIEW AND ANALYSIS OF CHAPTER 11- PASSIVE SMORING AND HEART
DISEASE: EPIDEMIOLOGY, PHYSIOLOGY, AND BIOCHEMISTRY
In this chapter, Stanton A. Glantz, Ph.D., and William W.
Parmley, M.D., make a large number of statements concerning
environmental tobacco smoke (ETS) and coronary heart disease. Many
of these statements deserve comment, but the following five state-
ments especially so:
1. "The action of ETS to increase platelet aggregation is another
way in which ETS can acutely increase the risk of a coronary
event." (page 9, paragraph 2, lines 1-2)
2. "Regardless of whether the monoclonal hypothesis proves to be
true (or, more likely, one of several initiators of the
atherosclerotic process), the fact is that there is clear
evidence that components of ETS, in particular PAHs such as
benzo(a)pyrene, initiate or accelerate the development of
plaque....The PAHs in ETS are clearly implicated at
epidemiological, physiological and biochemical levels in the
genesis of heart disease." (page 16, paragraph 2, beginning
at line 4)
3. "Exposure to ETS also increased resting heart rate and
systolic and diastolic blood pressure, and resulted in a lower
1

heart rate at the onset of angina (Aronow, 1978)." (page 7,
paragraph 1, lines 8-12)
4. "There are ten epidemiological studies, done in a variety of
locations, which reflect a 20%-30% increase in risk of death
from ischemic heart disease or myocardial infarction among
nonsmokers living with smokers." (page 16, paragraph 3, lines
4-7)
5. "The combination of epidemiological studies with demonstration
of physiological changes with exposure to ETS, together with
biochemical evidence that elements of ETS have significant
effects on the cardiovascular system, lead to the conclusion
that ETS causes heart disease." (page 17, paragraph 3, lines
2-6 )
Analysis of Statement 1
This section gives the reader who is not familiar with the
literature the impression that cigarette smoking is consistently
associated with shortened bleeding times and enhanced platelet
aggregation. The following summary illustrates that there is a
significant body of recent literature (1980's) which does not
suggest an association between smoking and increased platelet
aggregation. This summary is by no means comprehensive as there
are many additonal studies which could be discussed.
2

M.T. Kampman and G. Hornstra. No acute effect of cigarette smoking
on bleeding time of habitual smokers. Thrombosis Research 51; 287-
294, 1988 (1):
"To study the influence of cigarette smoking on blood platelet
function, bleeding time was measured in two groups of 14 habitual
smokers before and after a 20-minute period during which the
subjects either smoked two cigarettes (experimental group) or
rested (control group). The second bleeding time appeared to be
slightly shortened upon cigarette-smoking (-0.1 min) and was found
to be prolonged in the control group (+0.4 min). These changes did
not differ significantly from each other (P = 0.38). Consequently,
bleeding time of habitual smokers is not affected by smoking two
cigarettes."
R.R. Taylor et al. Whole blood platelet aggregation is not
affected by cigarette smoking but is sex-related. Clinical and
Experimental Pharmacology & Physiolody 14; 665-671, 1987 (2).
"1.
In normal subjects, 18-49 years old, the effects of the
smoking habit (> 10 cigarettes/day) and the act of smoking two
cigarettes over 10 min were studied on whole blood aggregation (in
vitro impedance method).
"2. Acute smoking (n = 10) did not affect platelet aggregation to
3

ADP, collagen or to platelet activating factor (PAF) nor
thromboxane B2 production during aggregation. There was no
difference between smokers (n = 13) and nonsmokers (n = 12) (ADP
and collagen, P < 0.001; PAF, P < 0.01; ANOVA).
"3. Although others have obtained diverse results studying
platelet-rich plasma, the absence of an effect of cigarette smoking
on whole blood platelet aggregation is consistent with many of
those observations. Greater in vitro aggregability in females than
males is consistent with the few studies of platelet-rich plasma.
It seems unlikely that the role of cigarette smoking as a risk
factor for ischaemic heart disease is related to a direct effect
on platelet aggregability."
Matti Hillbom et al. Platelet thromboxane formation and bleeding
time is influenced by ethanol withdrawal but not by cigarette
smoking. Thrombosis and Haemostasis 53(3); 419-422, 1985 (3):
"Platelet count, mean volume, aggregation and associated
thromboxane (TXB2) formation, circulating platelet aggregates and
bleeding time were examined in 19 noncirrhotic male alcoholic
cigarette smokers for four weeks following cessation of prolonged
heavy drinking, and in 24 nonalcoholic healthy male volunteers (10
smokers and 14 nonsmokers). The alcoholics showed a 9-fold
increase (p < 0.001) in ADP-stimulated platelet thromboxane
formation one to two weeks after ethanol withdrawal. The effect
4

was transient and coincided with
a significant (p < 0.01)
shortening of skin bleeding time and a slight increase in
circulating platelet aggregates suggesting proneness to thrombosis.
No differences were seen between the smoking and nonsmoking healthy
volunteers. We conclude that the recovery phase after prolonged
heavy drinking is characterized by a transient increase in platelet
reactivity which may lead to increased spontaneous formation of
circulating platelet aggregates and shortening of bleeding time."
T.W. Mead et al. Epidemiological characteristics of platelet
aggrega.-_~i i +-~y... nL ~.. a~..;~1--0~.7~. MeAinal .Tn~4rnal ?9f12 79f~5 (4)S
~~
~ l.L .-.~~..~~ . .,-
"The epidemiological characteristics of platelet aggregability were
established in 958 participants in the Northwick Park Heart Study.
The main analyses were based on the dose of adenosine diphosphate
at which primary aggregation occurred at half its maximum velocity.
Aggregability increased with age in both sexes, was greater in
whites than blacks (particularly among men) and tended to decrease
with the level of habitual alcohol consumption. Aggregability was,
however, greater in women than men and in nonsmokers than smokers.
There was no relation betwen aggregability on the one hand and
obesity, current or past oral contraceptive use, menopausal state,
or blood cholesterol and triglyceride concentrations on the other.
Aggregability was somewhat, though not significantly, higher in men
with a history of ischaemic heart disease and in those with
electrocardiographic evidence of ischaemia than in those without.
5

There was a strong association between the plasma fibrinogen
concentration and aggregability."
R.F. Davis and J.W. Davis. The effect of smoking on the stressed
template bleeding time: Annals of Clinical Research 15; 131-133,
1983 (5).
"Tobacco cigarette smoking is known to affect platelet function.
The purpose of this study was to determine whether cigarette
smoking acutely shortens the bleeding time of healthy men. The
mean initial stressed template bleeding time of 10 nonsmokers (9.0
minutes) was not significantly different from that of nine habitual
smokers (9.2 minutes) who were asked to abstain from smoking for
12 hours before determination of the bleeding time. The mean
bleeding time was the same immediately before and after the 21 men
smoked two filtered tobaccco cigarettes in 20 minutes. Separate
analyses showed that the mean bleeding time of neither the
nonsmokers nor the habitual smokers changed significantly after
experimental smoking. We conclude that smoking two cigarettes has
no effect on the stressed template bleeding time of healthy men."
Analysis of Statement 2
The contention that the extremely low levels of chemical
compounds found in ETS are atherogenic is not supported by evidence
6
